10th International Global Network (GVN) Meeting

Organized by the Global Virus Network (GVN), The Mérieux Foundation (MF) & University of Veterinary Medicine Hannover (TiHo)

Les Pensieres Center for Global Health, Veyrier-Du-Lac,

November 28-30th, 2018

Scientific Organizing Committee

Members Institutions Global Virus Network Dr. Christian Bréchot

Fondation Mérieux and the Global Virus Netowork Dr. Juliet Bryant

Fondation Mérieux and Global Virus Netowork Dr. Hubert Endtz

Institute of Human at the University of School of Dr. Robert C. Gallo Medicine and the Global Virus Network

Global Virus Network Dr. Natalia Mercer

University of Veterinary Medicine Hannover and the Global Dr. Ab Osterhaus Virus Network

Fondation Mérieux Dr. Valentina Picot

Meeting Coordinator: Cindy Grasso, Fondation Mérieux

Scientific Program

Wednesday, November 28th, 2018

13h00-13h30 Registration

Christian Bréchot, Global Virus Network, 13h30-14h00 Welcome addresses Alain Mérieux, Fondation Mérieux, Ab Osterhaus, University of Veterinary Medicine Hannover

Eradication of Session 1 Chair: (20 min presentation + 5 min discussion for each speaker)

14h00-14h25 Smallpox Mariano Esteban, CNB,

14h25-14h50 Measles Diane Griffin, JHU, USA

14h50-15h15 Polio Viruses: what are the final stumble Michel Zaffran, WHO blocks?

Malik Peiris, University of Hong 15h15-15h40 SARS eradication Kong, Hong Kong

Joaquim Ségales, CRESA, 15h40-16h05 Role of animal reservoirs Spain

16h05-16h35 Coffee break

Programmatic issues relating to Rino Rappuoli, GSK, 16h35-17h00 immunization John Mackenzie, Curtin delivery/access/coverage??] or health University, Australia economics?

17h00-17h25 CEPI: development of for Melanie Saville?TBC, CEPI emerging viruses

Retroviruses: emergence and intervention strategies Session 2 Chair: (20 min presentation + 5 min discussion for each speaker)

Sharon Lewin, Doherty 17h25-17h50 HIV: HIV prevalence and pathogenesis Institute, Australia Jean-Louis Excler, IVI, South 17h50-18h15 HIV development Korea Robert C. Gallo, IHV at UMD, 18h15-18h40 HTLV’s origins and evolution USA Joshua James Anzinger, The 18h40-19h05 HIV in the Caribbean University of the West Indies at Mona, West Indies 19h15 Dinner

Thursday, November 29th, 2018

Arboviruses: emergence and intervention strategies Session 3 Chair: (20 min presentation + 5 min discussion for each speaker)

Johan Neyts, University of 8h05-8h30 Antiviral strategies Leuven, Yellow Fever (re-emergence/ vaccine manufacturing dose shortage/ studies of Maurício Lacerda Nogueira, 8h30-8h55 dose saving and new production FAMERP, Brazil methods) Pathogenesis and clinical disease for Marc Lecuit, Institut 8h55-9h20 CHIKV and ZIKV Pasteur, France

9h20-9h45 Dengue Vaccine Joachim Hombach, WHO

ZIKA and CHIKV: epidemiology and 9h45-10h10 Scott Weaver, UTMB, USA vector transmission 10h10-10h40 Coffee break

10h40-11h05 Japanese encephalitis virus Masayuki Saijo, NIID,

Gerhard Dobler, TBEV: Eurasian spread and vaccine 11h05-11h30 Bundeswehr Munchen, development Amadou Sall, Institut 11h30-11h55 RVF virus Pasteur, Senegal Diagnosis and emergence potential of Xavier de Lamballerie, Aix- 11h55-12h20 arboviruses Marseille University, France Aaron S. Mweene, 12h20-12h45 TBC University of Zambia, Zambia 12h45-14h45 Group Picture and Lunch

Filo- and other HF viruses: outbreaks & preparedness Session 4 Chair: (20 min presentation + 5 min discussion for each speaker)

Stephan Becker, University of 14h45-15h10 Ebola and Marburg viruses Marburg, Germany Noel Tordo, Institut Pasteur, 15h10-15h35 Hanta viruses France Erica Ollman Saphire, Scripps, 15h35-16h00 Ebola USA

16h00-16h25 Lassa Robert Garry, Tulane Univeristy, USA 16h25-16h55 Coffee break

Respiratory Viruses Session 5 Chair: (20 min presentation + 5 min discussion for each speaker)

Pathogenesis and impact of respiratory Peter Openshaw, Imerial 16h55-17h20 viruses College London, UK

Ab Osterhaus, Univeristy of New kids on the block: an update: Flu, 17h20-17h45 Veterinary Medicine Hannover, HMPV, SARS/MERS, rhino Germany

RSV - latest update on phase III trials of 17h45-18h10 Michelle Crank, NIH, USA pre-fusion F vaccines

Adolfo Garcia-Sastre, Icahn 18h10-18h35 Influenza universal vaccines School of Medicine at Mt. Sinai, USA Respiratory viruses in 18h35-19h00 Meagan Deming, IHV, USA immunocompromised hosts 19h00 Dinner

Friday, November 30th, 2018

Viruses affecting the CNS and PNS: challenges Session 6 Chair: (20 min presentation + 5 min discussion for each speaker)

Harry Dalton, University of 8h30-8h55 HEV amd neurological disease Execter, UK

8h55-9h20 Rabies virus TBC

Justin Chu, National 9h20-9h45 Enteroviruses EV69/71 University, Singapore Bernie Roizman, The 9h45-10h10 Herpes viruses University of Chicago, USA

10h10-10h35 Flaviviruses Jim Sejvar, CDC, USA

10h35-11h05 Coffee break

Viral threats in crisis settings Session 7 Chair: (20 min presentation + 5 min discussion for each speaker)

Battle against Respiratory Viruses 11h05-11h30 TBC, WHO (BRaVe) initiative Virus threats and vaccination programs 11h30-11h55 in refugee setting (measles, RSV, flu, Stephen Chacko, WHO hepatitis A, rota, STD’s) Hubert Endtz, Fondation 11h55-12h20 Respiratory diseases and refugees Mérieux

12h20-13h20 Global Health Roundtable

The GVN Robert C. Gallo Award for 13h20-13h30 Scientific Excellence and Leadership Ceremony

13h30 Closing remarks & end of the meeting